Literature DB >> 1211497

Pentobarbital and contraction of vascular smooth muscle.

B T Altura, B M Altura.   

Abstract

This study, with isolated rat aortic strips and portal veins, was undertaken to : 1) study the effects, if any, of pentobarbital Na (PTB) (5 x 10(-5) to 2 X 10(-3) M) on reactivity to epinephrine, serotonin, and KCl; 2) determine whether certain concentrations of PTB induce direct actions on aortic strips and portal veins; and 3) gain some insight into how these effects are brought about. The results indicate that PTB can: a) inhibit development of spontaneous mechanical activity in these vessels in anesthetic concentrations; b) dose-dependently attenuate contractions induced by epinephrine, serotonin, and KC1; c) cause a noncompetitive type displacement of the dose response curves of these vasoactive agents; d) attenuate Ca2+- induced contractions of potassium-depolarized aortic strips and portal veins concomitant with a dose-dependent displacement of these dose-response curves to the right; and e) rapidly relax drug as well as Ca2+ -induced contractions of aortas and portal veins. In addition, the data indicate that rat portal venous smooth muscle is more sensitive to the inhibitory actions of PTB than rat aortic smooth muscle. Overall, these data suggest that concentrations of PTB used to induce surgical anesthesia can exert profound depressant effects on at least two different types of vascular smooth muscle that may be related to actions on movement and/or translocation of Ca2+.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211497     DOI: 10.1152/ajplegacy.1975.229.6.1635

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats.

Authors:  P Lacolley; N Ghodsi; E Glazer; P Challande; A M Brissac; M E Safar; S Laurent
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

2.  Adverse effects of artificial buffers on contractile responses of arterial and venous smooth muscle.

Authors:  B M Altura; B T Altura; A Carella; P D Turlapaty
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

3.  The effects of pentobarbitone and chloralose anaesthesia on the vagal component of bronchoconstriction produced by histamine aerosol in the anaesthetized dog.

Authors:  D M Jackson; I M Richards
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

4.  [Hemodynamic interferences between diltiazem and thiopental--experimental study in the pig].

Authors:  M Pierrot; M Blaise; S Hugon; F Bonnel; M Cupa
Journal:  Can Anaesth Soc J       Date:  1984-03

5.  The relaxing effects of barbiturates in vascular smooth muscle of rat aorta.

Authors:  M Nishiwada; K Nakamura; Y Hatano; K Mori
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

6.  Renal sympathetic baroreflex during normoxia and during hypoxia in conscious and in anesthetized rabbits.

Authors:  M Iriki; E Kozawa
Journal:  Pflugers Arch       Date:  1983-06       Impact factor: 3.657

7.  Measurement of arterial pressure-dimension relationships in conscious animals.

Authors:  S F Vatner; A Pasipoularides; I Mirsky
Journal:  Ann Biomed Eng       Date:  1984       Impact factor: 3.934

8.  Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.

Authors:  D M Nganele; V M DeLeonardis; T H Hintze
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

9.  Experimental study on the indications for barbiturate therapy. Change in haemodynamics and the influence of dopamine.

Authors:  M Sato; K Niiyama; R Kuroda; M Ioku; N Kanai; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

10.  Spectrum Degradation of Hippocampal LFP During Euthanasia.

Authors:  Yuchen Zhou; Alex Sheremet; Jack P Kennedy; Nicholas M DiCola; Carolina B Maciel; Sara N Burke; Andrew P Maurer
Journal:  Front Syst Neurosci       Date:  2021-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.